84 related articles for article (PubMed ID: 18428114)
1. Polymeric particles conjugated with a ligand to VCAM-1 exhibit selective, avid, and focal adhesion to sites of atherosclerosis.
Deosarkar SP; Malgor R; Fu J; Kohn LD; Hanes J; Goetz DJ
Biotechnol Bioeng; 2008 Oct; 101(2):400-7. PubMed ID: 18428114
[TBL] [Abstract][Full Text] [Related]
2. Enhanced adhesion of ligand-conjugated biodegradable particles to colitic venules.
Sakhalkar HS; Hanes J; Fu J; Benavides U; Malgor R; Borruso CL; Kohn LD; Kurjiaka DT; Goetz DJ
FASEB J; 2005 May; 19(7):792-4. PubMed ID: 15764649
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis.
Nahrendorf M; Jaffer FA; Kelly KA; Sosnovik DE; Aikawa E; Libby P; Weissleder R
Circulation; 2006 Oct; 114(14):1504-11. PubMed ID: 17000904
[TBL] [Abstract][Full Text] [Related]
4. Adhesion of T and B lymphocytes to mouse atherosclerotic aortas: association with lesion topology and VCAM-1 expression.
Møller F; Andersen CB; Nielsen LB
Scand J Clin Lab Invest; 2005; 65(7):559-70. PubMed ID: 16271987
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of VCAM-1 antibodies as therapeutic agent for atherosclerosis in apolipoprotein E-deficient mice.
Park JG; Ryu SY; Jung IH; Lee YH; Kang KJ; Lee MR; Lee MN; Sonn SK; Lee JH; Lee H; Oh GT; Moon K; Shim H
Atherosclerosis; 2013 Feb; 226(2):356-63. PubMed ID: 23245509
[TBL] [Abstract][Full Text] [Related]
6. In vivo evaluation of vascular-targeted spheroidal microparticles for imaging and drug delivery application in atherosclerosis.
Namdee K; Thompson AJ; Golinski A; Mocherla S; Bouis D; Eniola-Adefeso O
Atherosclerosis; 2014 Nov; 237(1):279-86. PubMed ID: 25286447
[TBL] [Abstract][Full Text] [Related]
7. Endothelial CD81 is a marker of early human atherosclerotic plaques and facilitates monocyte adhesion.
Rohlena J; Volger OL; van Buul JD; Hekking LH; van Gils JM; Bonta PI; Fontijn RD; Post JA; Hordijk PL; Horrevoets AJ
Cardiovasc Res; 2009 Jan; 81(1):187-96. PubMed ID: 18805782
[TBL] [Abstract][Full Text] [Related]
8. Targeting therapeutics to the vascular wall in atherosclerosis--carrier size matters.
Charoenphol P; Mocherla S; Bouis D; Namdee K; Pinsky DJ; Eniola-Adefeso O
Atherosclerosis; 2011 Aug; 217(2):364-70. PubMed ID: 21601207
[TBL] [Abstract][Full Text] [Related]
9. Endothelial nitric oxide deficiency reduces MMP-13-mediated cleavage of ICAM-1 in vascular endothelium: a role in atherosclerosis.
Tarín C; Gomez M; Calvo E; López JA; Zaragoza C
Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):27-32. PubMed ID: 18988893
[TBL] [Abstract][Full Text] [Related]
10. Identification of a peptide ligand recognizing dysfunctional endothelial cells for targeting atherosclerosis.
Thapa N; Hong HY; Sangeetha P; Kim IS; Yoo J; Rhee K; Oh GT; Kwon IC; Lee BH
J Control Release; 2008 Oct; 131(1):27-33. PubMed ID: 18680772
[TBL] [Abstract][Full Text] [Related]
11. Active targeting of early and mid-stage atherosclerotic plaques using self-assembled peptide amphiphile micelles.
Mlinar LB; Chung EJ; Wonder EA; Tirrell M
Biomaterials; 2014 Oct; 35(30):8678-86. PubMed ID: 25043572
[TBL] [Abstract][Full Text] [Related]
12. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice.
Wang Y; Zhao X; Jin H; Wei H; Li W; Bu D; Tang X; Ren Y; Tang C; Du J
Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):173-9. PubMed ID: 18988885
[TBL] [Abstract][Full Text] [Related]
13. Continuously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein E-deficient mice.
Ortiz MA; Campana GL; Woods JR; Boguslawski G; Sosa MJ; Walker CL; Labarrere CA
Exp Biol Med (Maywood); 2009 Jun; 234(6):624-31. PubMed ID: 19359657
[TBL] [Abstract][Full Text] [Related]
14. Vascular cell adhesion molecule-1 expression in endothelial cells exposed to physiological coronary wall shear stresses.
O'Keeffe LM; Muir G; Piterina AV; McGloughlin T
J Biomech Eng; 2009 Aug; 131(8):081003. PubMed ID: 19604015
[TBL] [Abstract][Full Text] [Related]
15. Development of receptor for advanced glycation end products-directed imaging of atherosclerotic plaque in a murine model of spontaneous atherosclerosis.
Tekabe Y; Li Q; Rosario R; Sedlar M; Majewski S; Hudson BI; Einstein AJ; Schmidt AM; Johnson LL
Circ Cardiovasc Imaging; 2008 Nov; 1(3):212-9. PubMed ID: 19808545
[TBL] [Abstract][Full Text] [Related]
16. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice.
Sun L; Ishida T; Yasuda T; Kojima Y; Honjo T; Yamamoto Y; Yamamoto H; Ishibashi S; Hirata K; Hayashi Y
Cardiovasc Res; 2009 May; 82(2):371-81. PubMed ID: 19176597
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-alpha does not mediate diabetes-induced vascular inflammation in mice.
Nilsson-Ohman J; Fredrikson GN; Nilsson-Berglund LM; Gustavsson C; Bengtsson E; Smith ML; Agardh CD; Agardh E; Jovinge S; Gomez MF; Nilsson J
Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1465-70. PubMed ID: 19755528
[TBL] [Abstract][Full Text] [Related]
18. Vascular cell adhesion molecule-1: a viable therapeutic target for atherosclerosis?
Preiss DJ; Sattar N
Int J Clin Pract; 2007 Apr; 61(4):697-701. PubMed ID: 17394445
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of contrast-enhanced US and magnetic microbubbles targeted to vascular cell adhesion molecule-1 for molecular imaging of atherosclerosis.
Wu J; Leong-Poi H; Bin J; Yang L; Liao Y; Liu Y; Cai J; Xie J; Liu Y
Radiology; 2011 Aug; 260(2):463-71. PubMed ID: 21555346
[TBL] [Abstract][Full Text] [Related]
20. Atherosclerosis development in apolipoprotein E-null mice deficient for CD69.
Gómez M; Sanz-González SM; Abu Nabah YN; Lamana A; Sánchez-Madrid F; Andrés V
Cardiovasc Res; 2009 Jan; 81(1):197-205. PubMed ID: 18703531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
